Why partner with DHR Health Institute for Research & Development for clinical research?
We, at DHR Health Institute for Research & Development recognized that an industry-wide, collaborative effort was needed to provide the latest and most promising treatments to our patients in the Rio Grande Valley. Our patient population suffers from key chronic illnesses including Diabetes, Obesity, Cardiovascular Diseases, Non-alcoholic Fatty Liver Disease, Cancers and others.
Since its inception, the DHR Health Institute for Research & Development has successfully enrolled hundreds of patients in clinical research studies across several therapeutic areas and continues to seek productive collaborations with key thought leaders in both industry and academic research settings. The increase in patient enrollment is testament to our commitment to increasing participation of the Latino community in clinical trials, both interventional and non-interventional.
Our clinical trial unit (CTU) is staffed by highly qualified study coordinators with vast experience in this arena of clinical research. We deliver high quality data to our partners and consistently maintain the safety of all our clinical trial participants.
Our focus is on the three following milestones to ensure that we are valuable to our partners:
Why select our site to conduct your clinical trial?
Delivery of quality data throughout clinical trial
Stable Patient Population
90% Hispanic Population with a majority of Mexican descent
Rapid turnaround time for study-start up documentations
Rapid response to sponsor queries
State of the art facilities to meet all clinical trial specifications
Robust patient recruitment, enrollment and retentions strategies
Clinical Trial Support (CTU)
Our CTU has the capabilities to successfully support the following range of clinical trials:
Phases: I, II, III, and IV
Types: Diagnostic, Proof of Concept, Safety, Nutrition, Prevention, Intervention
Our physician investigators have vast experience in the following areas of clinical research:
Non-alcoholic fatty liver disease and Non-alcoholic steatosis hepatitis (NAFLD/NASH)
Cardiovascular Disease
Diabetes/Diabetic Nephropathy and Retinopathy
Metabolic Diseases
Neurosciences (Stroke, Movement Disorders, Epilepsy, etc.)
Greater than 90% Hispanic population of Mexican descent
Key chronic diseases are overwhelmingly present in our Rio Grande Valley (RGV) patient population including Diabetes, Obesity (see graphs below), and Cardiovascular disease
RGV patient population presents with unique pathology, medical history and varying pharmacological response to existing therapeutic regimens.
PHR11, Texas Public Health Region 11; Data obtained from the Center for Disease Control, 2016.
PHR11, Texas Public Health Region 11; Data obtained from the Center for Disease Control, 2016.
